AZN - AstraZeneca AB Forecast Levels Chart

The AstraZeneca PLC (AZN) share price visualized below is based on the 228.73 metric. AstraZeneca PLC develops advanced treatments for cancer and orphan diseases by implementing breakthrough molecules. Its status as a global medical leader is confirmed by the creation of critical vaccines. Strict patent restrictions, the high cost of clinical trials, and effective engagement with government regulators ensure the business's resilience.

AZN (AstraZeneca Corp.) Price Target Chart history from 07/04/2022 to 11/11/2026

Analytical breakdowns for AstraZeneca AB (AZN)

- stock value and consensus price forecast:

Stock Price astrazeneca.com|AZN - Consensus Target

- market capitalization statistics:

Market Valuation AstraZeneca AB|AZN - Total Company Value

- balance sheet net asset value indicators:

Equity per Share AstraZeneca|AZN - Company Book Value|Market Capitalization to Net Assets astrazeneca.com|AZN - Company Total Assets

- issuer credit burden and liquidity indicators:

- net income and valuation multiples indicators:

AZN - Net Income|Expected Net Income AstraZeneca PLC|AZN - P/E Multiple|Future Price to Earnings Multiple AstraZeneca Plc|AZN - Price/Earnings to Growth Ratio|Company Value to EBITDA AstraZeneca AB|AZN - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months AstraZeneca|AZN - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last 12 months astrazeneca.com|AZN - Earnings growth in current year|Consensus forecast of earnings per share growth for next year AstraZeneca PLC

Fundamental company analysis:astrazeneca.com, AZN

A comparative asset analysis requires benchmarking current quotes against a consensus fair value estimate, which represents the weighted average of target prices from leading investment houses. For AstraZeneca PLC (AZN), this indicator reflects market expectations regarding the success of multi-billion dollar R&D projects and the complexity of navigating stringent government regulatory filters, thereby determining the fundamental value trajectory of the shares.

Competitors of AstraZeneca PLC